http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101835108-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-0008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-761 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-761 |
| filingDate | 2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101835108-B1 |
| titleOfInvention | Pharmaceutical Composition for Preventing or Treating Diabetes Comprising Recombinant Adenovirus Expressing PREB |
| abstract | The present invention provides a pharmaceutical composition for the prevention or treatment of diabetes comprising as an active ingredient a recombinant adenovirus comprising a nucleotide sequence encoding a prolactin regulatory element-binding protein (PREB). The composition of the present invention can effectively prevent and treat diabetes, especially type 2 diabetes, by reducing the resistance of glucose and pyruvic acid and inhibiting your biosynthesis. |
| priorityDate | 2016-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 229.